A groundbreaking discovery from researchers at the Hebrew University of Jerusalem could transform cancer immunotherapy by turning ordinary immune cells into far more powerful...
Rivian founder and CEO RJ Scaringe is stepping into the fast-growing AI robotics arena with a major new venture that promises to transform industrial...